A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in lung cancer.
Di Leva, G
AffiliationDepartment of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, OH 43210
MetadataShow full item record
AbstractTRAIL (TNF-related apoptosis-inducing ligand) is a promising anticancer agent that can be potentially used as an alternative or complementary therapy because of its specific antitumor activity. However, TRAIL can also stimulate the proliferation of cancer cells through the activation of NF-κB, but the exact mechanism is still poorly understood. In this study, we show that chronic exposure to subtoxic concentrations of TRAIL results in acquired resistance. This resistance is associated with the increase in miR-21, miR-30c, and miR-100 expression, which target tumor-suppressor genes fundamental in the response to TRAIL. Importantly, down-regulation of caspase-8 by miR-21 blocks receptor interacting protein-1 cleavage and induces the activation of NF-κB, which regulates these miRNAs. Thus, TRAIL activates a positive feedback loop that sustains the acquired resistance and causes an aggressive phenotype. Finally, we prove that combinatory treatment of NF-κB inhibitors and TRAIL is able to revert resistance and reduce tumor growth, with important consequences for the clinical practice.
CitationA set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer. 2015, 112 (26):E3355-64 Proc Natl Acad Sci
JournalProceedings of the National Academy of Sciences
- Over-expressing CYLD augments antitumor activity of TRAIL by inhibiting the NF-κB survival signaling in lung cancer cells.
- Authors: Deng LL, Shao YX, Lv HF, Deng HB, Lv FZ
- Issue date: 2012
- TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration.
- Authors: Wang D, Liu D, Gao J, Liu M, Liu S, Jiang M, Liu Y, Zheng D
- Issue date: 2013 Jul
- Tumor necrosis factor-related apoptosis-inducing ligand induces the expression of proinflammatory cytokines in macrophages and re-educates tumor-associated macrophages to an antitumor phenotype.
- Authors: Gao J, Wang D, Liu D, Liu M, Ge Y, Jiang M, Liu Y, Zheng D
- Issue date: 2015 Sep 15
- Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation.
- Authors: Lee KY, Park JS, Jee YK, Rosen GD
- Issue date: 2002 Dec 31
- RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival.
- Authors: Zhang L, Blackwell K, Workman LM, Chen S, Pope MR, Janz S, Habelhah H
- Issue date: 2015 Oct